Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.470
+1.470 (0.00%)
Feb 28, 2025, 3:00 PM EST

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Feb '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
204325672547715611
Upgrade
Market Cap Growth
-51.64%-51.64%22.71%-23.44%17.04%-
Upgrade
Enterprise Value
20152600448612549
Upgrade
Last Close Price
1.472.631.503.257.156.97
Upgrade
PS Ratio
6.006.0016.6720.9842.5381.67
Upgrade
PB Ratio
1.941.9423.9820.5861.9349.39
Upgrade
P/TBV Ratio
2.092.0945.2633.06580.25487.96
Upgrade
P/FCF Ratio
----96.09-
Upgrade
P/OCF Ratio
----77.58-
Upgrade
EV/Sales Ratio
0.362.8114.8917.1636.4073.34
Upgrade
EV/FCF Ratio
-0.23---82.24-
Upgrade
Debt / Equity Ratio
0.000.000.020.020.020.04
Upgrade
Debt / FCF Ratio
----0.02-
Upgrade
Asset Turnover
0.270.270.280.210.140.08
Upgrade
Quick Ratio
10.3610.364.154.035.412.77
Upgrade
Current Ratio
11.1411.144.624.415.692.99
Upgrade
Return on Equity (ROE)
-58.08%-58.08%-246.13%-329.00%-448.22%-217.21%
Upgrade
Return on Assets (ROA)
-19.24%-19.24%-28.88%-31.43%-31.44%-29.33%
Upgrade
Return on Capital (ROIC)
-39.61%-39.61%-146.11%-205.33%-317.04%-126.58%
Upgrade
Earnings Yield
-27.80%-17.46%-10.28%-11.08%-7.46%-7.27%
Upgrade
FCF Yield
-41.64%-26.15%-9.39%-12.59%1.04%-2.52%
Upgrade
Buyback Yield / Dilution
-24.69%-24.69%-15.21%-8.58%-8.78%-8.85%
Upgrade
Total Shareholder Return
-24.69%-24.69%-15.21%-8.58%-8.78%-8.85%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.